Pharmaceutical giant Pfizer has announced that a Phase 3, late-stage study found their potential COVID-19 vaccine showed more than 90% effectiveness. The two-dose vaccine still faces several challenges, including how to store and transport it, since it must be refrigerated at subzero temperatures. Pulitzer Prize-winning science journalist Laurie Garrett says the news is hopeful, but urges caution. “There’s been no scientific release. There’s no published data,” she says. “We don’t have anything to go with except what the lawyers at Pfizer massaged carefully into a single-page press release. So, we have to take that with a big caveat.”
#DemocracyNow
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: https://democracynow.org
Please consider supporting independent media by making a donation to Democracy Now! today: https://democracynow.org/donate
FOLLOW DEMOCRACY NOW! ONLINE:
YouTube: http://youtube.com/democracynow
Facebook: http://facebook.com/democracynow
Twitter: https://twitter.com/democracynow
Instagram: http://instagram.com/democracynow
SoundCloud: http://soundcloud.com/democracynow
iTunes: https://itunes.apple.com/podcast/democracy-now!-audio/id73802554
Daily Email Digest: https://democracynow.org/subscribe
Democracy Now | Radio Free (2020-11-22T06:21:04+00:00) As U.S. Faces Out-of-Control Pandemic, Pfizer Raises Hope for Vaccine, But Many Questions Remain. Retrieved from https://www.radiofree.org/2020/11/22/as-u-s-faces-out-of-control-pandemic-pfizer-raises-hope-for-vaccine-but-many-questions-remain-2/
Please log in to upload a file.
There are no updates yet.
Click the Upload button above to add an update.